YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

Phase 2

Terminated

Conditions: Adolescent Suicide
Adolescent Depression

Interventions: Drug: Ketamine Infusion
Drug: Midazolam Infusion

First Posted Date: 2020-11-03

Last Posted Date: 2024-12-19

Lead Sponsor: Yale University

Target Recruit Count: 11

Registration Number: NCT04613453

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Take 5 + Audio Clip Randomized Control Trial

Not Applicable

Completed

Conditions: Abuse, Child
Parent-Child Relations
Crying

Interventions: Behavioral: Take 5 and Audio Clip
Behavioral: Take 5 Only

First Posted Date: 2020-10-29

Last Posted Date: 2023-08-07

Lead Sponsor: Yale University

Target Recruit Count: 76

Registration Number: NCT04608877

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)

Phase 2

Conditions: Obesity/Overweight
Loss-of-Control Eating

Interventions: Drug: Naltrexone and Bupropion (NB) medication
Other: Placebo

First Posted Date: 2020-10-27

Last Posted Date: 2024-05-03

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT04605081

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)

Phase 2

Conditions: Loss-of-control Eating
Obesity/Overweight

Interventions: Drug: Lisdexamfetamine Dimesylate (Medication)
Other: Placebo

First Posted Date: 2020-10-22

Last Posted Date: 2024-05-03

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT04599504

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Phase 2

Recruiting

Conditions: Loss-of-control Eating
Obesity/Overweight

Interventions: Drug: Naltrexone and Bupropion medication
Behavioral: Behavioral Weight Loss
Other: Placebo

First Posted Date: 2020-10-22

Last Posted Date: 2024-07-23

Lead Sponsor: Yale University

Target Recruit Count: 160

Registration Number: NCT04599478

Locations: 🇺🇸
Yale Department of Psychiatry, New Haven, Connecticut, United States

Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women

Conditions: Exercise Test
Coronary Disease
Myocardial Perfusion Imaging
Cardiac Catheterization
Percutaneous Coronary Intervention

Interventions: Other: No study intervention

First Posted Date: 2020-10-22

Last Posted Date: 2025-01-09

Lead Sponsor: Yale University

Target Recruit Count: 500

Registration Number: NCT04599192

Locations: 🇺🇸
Yale University School of Medicine - Section of Cardiology, New Haven, Connecticut, United States

Cannabidiol in Opioid Use Disorder and Chronic Pain

Early Phase 1

Recruiting

Conditions: Chronic Pain

Interventions: Drug: 400mg Cannabidiol
Drug: 800mg Cannabidiol
Drug: 1200mg Cannabidiol
Drug: Saline

First Posted Date: 2020-10-14

Last Posted Date: 2024-03-06

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT04587791

Locations: 🇺🇸
Department of Veterans Affairs Hospital, West Haven, Connecticut, United States

Cognitive-Behavioral Therapy for Weight-related Bullying (Online Treatment)

Not Applicable

Completed

Conditions: Weight, Body
Trauma, Psychological
Bullying

Interventions: Behavioral: CBT for Weight Bullying

First Posted Date: 2020-10-14

Last Posted Date: 2023-09-13

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT04587752

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)

Phase 2

Terminated

Conditions: COVID-19

Interventions: Drug: PF-06650833
Drug: Placebo

First Posted Date: 2020-10-05

Last Posted Date: 2021-10-26

Lead Sponsor: Yale University

Target Recruit Count: 7

Registration Number: NCT04575610

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

Not Applicable

Recruiting

Conditions: Transthyretin Amyloidosis

Interventions: Device: Computer algorithm for ATTR

First Posted Date: 2020-09-30

Last Posted Date: 2024-08-15

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT04569903

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy